| Trial ID: | L0125 |
| Source ID: | NCT00699036
|
| Associated Drug: |
Rosiglitazone
|
| Title: |
Rosiglitazone Versus Rosiglitazone and Metformin Versus Rosiglitazone and Avandia in the Treatment of Nonalcoholic Steatohepatitis (NASH)
|
| Acronym: |
--
|
| Status: |
Unknown status
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Nonalcoholic Steatohepatitis|Nonalcoholic Fatty Liver Disease
|
| Interventions: |
Drug: avandia|Drug: metformin|Drug: losartan
|
| Outcome Measures: |
liver biopsy histologic improvement|serum transaminases
|
| Sponsor/Collaborators: |
Brooke Army Medical Center
|
| Gender: |
All
|
| Age: |
18 Years and older ?? (Adult, Older Adult)
|
| Phases: |
Phase 2
|
| Enrollment: |
165
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized|Intervention Model: Parallel Assignment|Masking: None (Open Label)|Primary Purpose: Treatment
|
| Start Date: |
April 2007
|
| Completion Date: |
August 2009
|
| Results First Posted: |
--
|
| Last Update Posted: |
June 19, 2009
|
| Locations: |
Brooke Army Medical Center, San Antonio, Texas, United States
|
| URL: |
https://ClinicalTrials.gov/show/NCT00699036
|
